Screener
Amgen AMGN EBITDA
EBITDA at other companies
Other financials
Where this comes from
Calculated from Amgen’s reported figures.
The source filing: Amgen’s 10-Q, filed April 30, 2026. Open the filing →
- Filed
- Apr 30, 2026, 7:04 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000318154-26-000057
FAQ
- What is Amgen's EBITDA?
- Amgen (AMGN) reported EBITDA of $3.78B in Q1 2026.
- How has Amgen's EBITDA changed year-over-year?
- Amgen's EBITDA increased by 47.4% year-over-year, from $2.57B to $3.78B.
- What is the long-term trend for Amgen's EBITDA?
- Over 4 years (2021 to 2025), Amgen's EBITDA has grown at a 6.6% compound annual growth rate (CAGR), from $11.04B to $14.25B.
- What does EBITDA mean?
- Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.
Ask your AI about Amgen's ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude